CTOs on the Move

Tissuetech

www.biotissue.com

 
Bio-Tissue®, a subsidiary of TissueTech™, is the leader in regenerative biologic therapies and ocular hygiene solutions for eye care professionals. Established in 1997, Bio-Tissue® serves an unmet need for better surgical and therapeutic alternatives for helping eye care professionals heal ocular surface conditions, such as keratitis, recurrent corneal erosions, conjunctivochalasis dry eye, pterygium and dry eye. Eye care professionals understand that good medicine is based on good science. Bio-Tissue® prides itself on developing products that meet the highest clinical standards, are based on quality research and scientific data, and provide innovative solutions for a range of ocular surface and lid margin ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Funding

Tissuetech raised $15M on 06/22/2015
Tissuetech raised $55.2M on 04/14/2019

Similar Companies

OEM Concepts

OEM Concepts is a Toms River, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Accountable Healthcare IPA

Accountable Healthcare IPA is a Signal Hill, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Organ Recovery Systems

Organ Recovery Systems is a Des Plaines, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Indian Health Care Resource Center of Tulsa

Indian Health Care Resource Center of Tulsa is a Tulsa, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Altru Health System

Altru Health System is a community-owned, integrated system with an acute care hospital, a specialty hospital, more than a dozen clinics in Grand Forks and the region, a large home care network, and a congregate living facility. It employs more than 200 physicians and 4,000 staff and has an annual net operating revenue of more than $450 million. As the first member of the Mayo Clinic Care Network, Altru’s providers have access to clinically integrated tools extending Mayo Clinic’s knowledge and expertise to patients.